|
Huang, Xi; Britto, Manuel D; Kear-Scott, Jamie L et al. (2014) The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamics. J Biol Chem 289:17203-14
|
|
de Vera, Ian Mitchelle S; Smith, Adam N; Dancel, Maria Cristina A et al. (2013) Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease. Biochemistry 52:3278-88
|
|
Huang, Xi; de Vera, Ian Mitchelle S; Veloro, Angelo M et al. (2013) Backbone ¹H, ¹³C, and ¹?N chemical shift assignment for HIV-1 protease subtypes and multi-drug resistant variant MDR 769. Biomol NMR Assign 7:199-202
|
|
Huang, Xi; de Vera, Ian Mitchelle S; Veloro, Angelo M et al. (2012) Inhibitor-induced conformational shifts and ligand-exchange dynamics for HIV-1 protease measured by pulsed EPR and NMR spectroscopy. J Phys Chem B 116:14235-44
|
|
Wallet, Mark A; Reist, Caroline M; Williams, Julie C et al. (2012) The HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation. J Leukoc Biol 92:795-805
|
|
Haraguchi, Soichi; Ho, Sarah K; Morrow, Matthew et al. (2011) Developmental regulation of P-glycoprotein activity within thymocytes results in increased anti-HIV protease inhibitor activity. J Leukoc Biol 90:653-60
|
|
Robbins, Arthur H; Coman, Roxana M; Bracho-Sanchez, Edith et al. (2010) Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes. Acta Crystallogr D Biol Crystallogr 66:233-42
|
|
Ho, Sarah K; Perez, Elena E; Rose, Stephanie L et al. (2009) Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor. AIDS 23:1631-40
|
|
Rodriguez, Carina A; Koch, Sarah; Goodenow, Maureen et al. (2008) Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children. Immunol Res 40:271-86
|
|
Ho, Sarah K; Coman, Roxana M; Bunger, Joshua C et al. (2008) Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response. Virology 378:272-81
|
Showing the most recent 10 out of 13 publications
